U.S. markets open in 5 hours 21 minutes
  • S&P Futures

    4,354.25
    +16.75 (+0.39%)
     
  • Dow Futures

    34,025.00
    +133.00 (+0.39%)
     
  • Nasdaq Futures

    14,943.00
    +83.25 (+0.56%)
     
  • Russell 2000 Futures

    1,816.40
    +7.30 (+0.40%)
     
  • Crude Oil

    91.65
    -0.06 (-0.07%)
     
  • Gold

    1,890.20
    +11.60 (+0.62%)
     
  • Silver

    23.27
    +0.53 (+2.33%)
     
  • EUR/USD

    1.0608
    +0.0040 (+0.38%)
     
  • 10-Yr Bond

    4.5970
    0.0000 (0.00%)
     
  • Vix

    16.71
    -0.63 (-3.63%)
     
  • GBP/USD

    1.2238
    +0.0032 (+0.26%)
     
  • USD/JPY

    148.9520
    -0.3220 (-0.22%)
     
  • Bitcoin USD

    27,138.79
    +702.46 (+2.66%)
     
  • CMC Crypto 200

    584.49
    +19.70 (+3.49%)
     
  • FTSE 100

    7,641.70
    +39.85 (+0.52%)
     
  • Nikkei 225

    31,857.62
    -14.90 (-0.05%)
     

Goldman Sachs Sees Sharp Upside In This Automotive Supplier - Read Why

  • Goldman Sachs analyst Mark DeLaney upgraded Visteon Corp (NASDAQ: VC) to Buy from Neutral with a price target of $156, up from $119, implying a 29.6% upside.

  • DeLaney believes that company-specific and cyclical factors will contribute to strong revenue and earnings growth.

  • Visteon has good company-specific revenue drivers contributing to its 800-1200 bps growth over auto production sales target, including the increasing use of digital instruments/displays in the vehicle and a growing EV-specific business, battery management systems in particular, the analyst notes.

  • DeLaney also expects auto production to have a multi-year recovery, and Visteon has above average incremental margins, which should position it well to grow earnings.

  • Price Action: VC shares are trading higher by 0.52% at $121.00 in premarket on the last check Tuesday.

Latest Ratings for VC

Feb 2022

Goldman Sachs

Upgrades

Neutral

Buy

Feb 2022

Baird

Maintains

Outperform

Feb 2022

Jefferies

Maintains

Buy

View More Analyst Ratings for VC

View the Latest Analyst Ratings

See more from Benzinga

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.